Autolus Therapeutics plc

Commercial-stage programmed T-cell company led by AUCATZYL, with expansion into pediatric oncology and autoimmune disease.

Back to company catalog

Hematologic malignancies & autoimmune disease · Programmed autologous CAR-T cell therapy · Commercial + Phase 2

Compare report options